十年间310例肺癌患者的临床资料回顾性分析

发布时间：2018-07-09 15:07

本文选题：肺癌 + 回顾性分析　；参考：《广西中医药大学》2017年硕士论文

【摘要】：目的:回顾性研究310例住院病人的临床治料,了解肺癌的一般临床特征及治疗疗效情况,为提高肺癌的临床治疗效果提供相对科学的依据。方法:回顾性总结分析柳州市中医院2007年至2016年肺癌患者病例资料,严格按照纳入及排除标准筛选病例,对符合条件的病例资料采用SPSS17.0软件进行统计分析。结果:(1)本次研究310例肺癌中位发病年龄为67岁,(2)汉族、壮族、其他民族组间前后5年发病人数比较,无统计学意义(P0.05)。(3)前后5年腺癌与鳞癌发病人数发生变化(P0.05)。(4)肺鳞癌与其他几种病理类型肺部感染存在差异(P0.05)。(5)肺腺癌与肺鳞癌中医证型不同(P0.05)。(6)左右两肺原发性肺癌中医证型比较,无统计学意义(P0.05)。(7)肺癌解剖分型及肺癌中医证型的性别比较,无统计学意义(P0.05)。(8)化疗结合中成药及中药汤剂比化疗结合中成药在改善中医症候积分、提高卡氏评分、降低CEA、控制瘤体大小,减轻恶心呕吐程度疗效更好(P0.05)。结论:(1)高龄、吸烟仍是肺癌发生的重要因素。(2)不同民族间前后5年肺癌发病情况可能不存在差异。(3)肺癌不同病理类型构成比在发生变化。(4)不同病理类型的中医证型及肺部感染情况存在差异。(5)因性别不同肺癌的中医证型与解剖分型也不同。(6)化疗结合中成药及中药汤剂在治疗肺癌上能取得良好的临床疗效。
[Abstract]:Objective: to retrospectively study the clinical materials of 310 inpatients with lung cancer, to understand the general clinical characteristics and therapeutic efficacy of lung cancer, and to provide a scientific basis for improving the clinical treatment effect of lung cancer. Methods: the data of lung cancer patients in Liuzhou traditional Chinese Medicine Hospital from 2007 to 2016 were analyzed retrospectively. The cases were screened according to the criteria of inclusion and exclusion. SPSS 17.0 software was used to analyze the data of eligible cases. Results: (1) the median age of lung cancer in this study was 67 years old. There was no significant difference (P0.05). (3) before and after 5 years of changes in the incidence of adenocarcinoma and squamous cell carcinoma (P0.05). (4) lung squamous cell carcinoma and several other pathological types of pulmonary infection differences (P0.05). (5) lung adenocarcinoma and lung squamous cell carcinoma TCM syndrome type difference (P0.05). (6) about two types of primary lung cancer syndrome comparison. There was no significant difference (P0.05). (7) in the anatomical classification of lung cancer and gender comparison of TCM syndrome type of lung cancer. There was no statistical significance (P0.05). (8) that chemotherapy combined with traditional Chinese medicine and traditional Chinese medicine decoction could improve the score of TCM symptoms and improve the score of cardinal score. Reduce CEA, control tumor size, reduce nausea and vomiting better (P0.05). Conclusion: (1) aged, Smoking is still an important factor in the occurrence of lung cancer. (2) there may be no difference in the incidence of lung cancer between different nationalities before and after 5 years. (3) the composition ratio of different pathological types of lung cancer is changing. (4) TCM syndromes and pulmonary infection of different pathological types are changing. (5) the TCM syndromes and anatomic types of lung cancer are different according to sex. (6) chemotherapy combined with traditional Chinese medicine and traditional Chinese medicine decoction can obtain good clinical effect in the treatment of lung cancer.
【学位授予单位】：广西中医药大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：R734.2

【参考文献】